Normalisation is medical misogyny and delays diagnosis
Sharnelle Vella, ABC Radio Melbourne breakfast co-host[/caption]
Mike Stephens, Director, Medicines policy and Programs at the National Aboriginal Community Controlled Health Organisation (NACCHO)[/caption]
Chastina Heck MPS, Chair of the PSA/NACCHO Aboriginal and Torres Strait Islander Pharmacy Practice Community of Specialty Interest (CSI).[/caption]
Philippa Chigeza, pharmacist at Logan Hospital.[/caption]
Is technology helping make medicine use in Australia safer?
After chairing the Medication Safety and Efficiency Conference, Deborah Hawthorne reflects on whether digital health is making care safer.
The role of the pharmacist in motor neurone disease
Motor neurone disease (MND) is a group of progressive, degenerative disorders of the motor neurones. Multidisciplinary care of patients is required as the disease progresses.
Chronic kidney disease: when the filters fail
Chronic kidney disease is a progressive long-term condition characterised by a gradual and usually irreversible decline in kidney function.
Q&A: CPD planning
PSA has developed a CPD planning tool available free to members, that intuitively helps pharmacists through each of the required steps.
Urinary incontinence: let’s talk about leaks
Incontinence often leads to reduced quality of life and is under-recognised due to stigma.
Real-time prescription monitoring comes to South Australia
South Australia is the latest state to introduce RTPM in a nation-wide effort to curb addiction, overdose and death.
